Correlation Between Grifols SA and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Grifols SA and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Grifols SA and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Grifols SA ADR and Bristol Myers Squibb, you can compare the effects of market volatilities on Grifols SA and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Grifols SA with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of Grifols SA and Bristol Myers.

Diversification Opportunities for Grifols SA and Bristol Myers

0.11
  Correlation Coefficient

Average diversification

The 3 months correlation between Grifols and Bristol is 0.11. Overlapping area represents the amount of risk that can be diversified away by holding Grifols SA ADR and Bristol Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol Myers Squibb and Grifols SA is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Grifols SA ADR are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol Myers Squibb has no effect on the direction of Grifols SA i.e., Grifols SA and Bristol Myers go up and down completely randomly.

Pair Corralation between Grifols SA and Bristol Myers

Given the investment horizon of 90 days Grifols SA is expected to generate 6.55 times less return on investment than Bristol Myers. In addition to that, Grifols SA is 1.38 times more volatile than Bristol Myers Squibb. It trades about 0.02 of its total potential returns per unit of risk. Bristol Myers Squibb is currently generating about 0.17 per unit of volatility. If you would invest  4,771  in Bristol Myers Squibb on August 26, 2024 and sell it today you would earn a total of  1,116  from holding Bristol Myers Squibb or generate 23.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Grifols SA ADR  vs.  Bristol Myers Squibb

 Performance 
       Timeline  
Grifols SA ADR 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Grifols SA ADR are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable technical and fundamental indicators, Grifols SA is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.
Bristol Myers Squibb 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.

Grifols SA and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Grifols SA and Bristol Myers

The main advantage of trading using opposite Grifols SA and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Grifols SA position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind Grifols SA ADR and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Transaction History
View history of all your transactions and understand their impact on performance
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Content Syndication
Quickly integrate customizable finance content to your own investment portal